Grifols Biomat Sandy represents a significant evolution in automated apheresis collection, designed to enhance the efficiency and safety of plasma and source plasma collection. This fully automated platform integrates advanced sensor technology with a user-friendly interface to optimize the entire donor management process. Its introduction into the market addresses the growing demand for high-quality raw materials used in the production of life-saving therapies.
Technical Innovation and Operational Efficiency
The core innovation of the Biomat Sandy lies in its integrated sensor technology, which facilitates precise monitoring of the apheresis process without the need for finger sensors or additional hardware. This system utilizes advanced optics to measure hematocrit and total protein levels directly within the collection path. Such technology minimizes handling and potential contamination points, leading to a more streamlined and reliable procedure for both the donor and the operator.
Enhanced Donor Safety and Comfort
Donor experience is a primary focus of the Sandy platform. The system is engineered to minimize tourniquet time and reduce the frequency of air breaks, which directly contributes to a more comfortable session. Features such a closed, sterile tubing set and gentle separation technology ensure that the collection process is not only efficient but also maintains the highest standards of donor safety and well-being, encouraging repeat donations.
Streamlined Workflow for Collection Centers For collection centers, the Biomat Sandy offers a substantial leap in operational workflow. The automation of complex parameters reduces the need for manual intervention, allowing skilled staff to focus on donor care rather than procedural monitoring. The integrated barcode scanning and data management capabilities ensure full traceability and compliance with regulatory standards, significantly reducing the administrative burden on collection sites. Key Feature Benefit Integrated Sensor Technology Real-time monitoring without finger sensors Closed System Enhanced sterility and donor safety Automated Data Management Improved compliance and reduced administrative work Quality and Purity of Source Plasma
For collection centers, the Biomat Sandy offers a substantial leap in operational workflow. The automation of complex parameters reduces the need for manual intervention, allowing skilled staff to focus on donor care rather than procedural monitoring. The integrated barcode scanning and data management capabilities ensure full traceability and compliance with regulatory standards, significantly reducing the administrative burden on collection sites.
The ultimate goal of any apheresis collection is the yield of high-purity source plasma. Grifols Biomat Sandy is specifically validated for source plasma collection, ensuring that the product meets the stringent quality requirements of the pharmaceutical industry. The consistent processing parameters enabled by the system result in plasma that is ideal for further fractionation into critical proteins such as albumin, immunoglobulins, and clotting factors.
Global Impact and Therapeutic Applications
The plasma collected using the Grifols Biomat Sandy platform serves as the foundational material for a wide array of therapeutic products. These derivatives are essential for treating primary immunodeficiencies, hereditary angioedema, and various bleeding disorders. By providing a reliable and scalable method for plasma collection, the Sandy system plays a crucial role in supporting global public health and the development of advanced therapies.
